The new consumer healthcare company will be based at a newly built campus in Weybridge

Phase Ib CodeBreaK study evaluated Lumakras in over ten different investigational combination regimens

A commonly available, FDA-approved oral diuretic pill may be a potential candidate for an Alzheimer’s disease treatment for […]

Supernus strikes $400M+ Adamas buyout as its top drug heads toward the patent cliff esagonowsky Mon, 10/11/2021 – […]

Mahase examines the “toxic” media stories about primary care that have left many GPs feeling demoralised and browbeaten […]

AbbVie’s Botox patent lawsuit is ‘very unlikely to derail’ Revance’s rival launch: analysts esagonowsky Mon, 10/11/2021 – 09:32

Ipsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team esagonowsky Mon, […]

Neuroscientists discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the […]

At the newly opened Deutsches Museum Nuremberg, the University of Bayreuth offers insights into its expertise in the […]

After her objective structured clinical examination (OSCE) in July, Eilidh Wilcockson, a third year medical student at Newcastle […]